Media Coverage
Source: The Deal
Media Coverage
10.10.13
Lannett Company, Inc., a manufacturer and distributor of generic versions of branded pharmaceutical products, raised $76.5 million in a confidentially marketed public offering of common stock.
The company is developing active pharmaceutical ingredients in order to vertically integrate its controlled-substance pharmaceutical products. According to its press release, Lannett plans to use the funds for research and development, marketing and acquisitions.
Pillsbury represented the underwriters, Roth Capital Partners, LLC, Canaccord Genuity Inc., Oppenheimer & Co., Inc. and Craig-Hallum Capital Group, LLC, in the offering.
The New York-based team,led by corporate and securities partner Jonathan Russo, included tax partner Harsha Reddy and corporate and securities associates Meredith Ervine and Ria Dutta. Intellectual property partner John Wetherell and counsel Michelle Mehok, based in the firm's San Diego North Country, also assisted on the deal.